Drug Shortage Report for 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION
Report ID | 95574 |
Drug Identification Number | 00828602 |
Brand name | LIDOCAINE HCL 0.4% AND 5% DEXTROSE INJ |
Common or Proper name | LIDOCAINE HCL 0.4% AND 5% DEXTROSE INJ |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE LIDOCAINE HYDROCHLORIDE |
Strength(s) | 50MG 4MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 500 mL (JB0973) |
ATC code | C01BB |
ATC description | ANTIARRHYTHMICS, CLASS I AND III |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-10-04 |
Actual start date | 2019-10-04 |
Estimated end date | 2019-11-18 |
Actual end date | 2019-11-18 |
Shortage status | Resolved |
Updated date | 2019-11-19 |
Company comments | Short-dated product with December 2019 expiry available with approval provided. For questions or concerns contact Baxter customer care (1.888.719.9955). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-11-19 | English | Compare |
v5 | 2019-11-18 | French | Compare |
v4 | 2019-11-18 | English | Compare |
v3 | 2019-10-05 | English | Compare |
v2 | 2019-10-04 | French | Compare |
v1 | 2019-10-04 | English | Compare |
Showing 1 to 6 of 6